Supernus Pharmaceuticals Ownership | Who Owns Supernus Pharmaceuticals?
Supernus Pharmaceuticals Ownership Summary
Supernus Pharmaceuticals is owned by 52.72% institutional investors, 5.41% insiders, and 41.87% retail investors. Blackrock is the largest institutional shareholder, holding 18.90% of SUPN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.12% of its assets in Supernus Pharmaceuticals shares.
SUPN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Supernus Pharmaceuticals | 52.72% | 5.41% | 41.87% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 26.69% | 10.91% | 62.39% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 10.39M | 18.90% | $278.00M |
| Blackrock funding, inc. /de | 10.00M | 18.13% | $361.53M |
| Vanguard group | 6.15M | 11.15% | $222.41M |
| Armistice capital | 4.84M | 8.77% | $174.87M |
| Dimensional fund advisors lp | 2.88M | 5.22% | $104.09M |
| Macquarie group | 2.63M | 4.77% | $95.06M |
| State street | 2.16M | 3.94% | $57.88M |
| Polar capital | 1.94M | 3.53% | $51.91M |
| Stephens investment management group | 1.75M | 3.18% | $63.35M |
| Renaissance | 1.60M | 2.90% | $57.81M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ashford capital management | 711.89K | 2.57% | $19.04M |
| Armistice capital | 4.84M | 2.39% | $174.87M |
| Third avenue management | 189.49K | 1.33% | $6.85M |
| S&t bank/pa | 112.19K | 1.29% | $4.06M |
| Aristotle capital boston | 1.20M | 1.08% | $32.18M |
| Rice hall james & associates | 528.35K | 1.05% | $19.10M |
| Tributary capital management | 343.96K | 0.96% | $12.44M |
| Bruce | 82.11K | 0.95% | $2.97M |
| Stephens investment management group | 1.75M | 0.85% | $63.35M |
| Bridge city capital | 82.28K | 0.74% | $2.20M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Woodline partners lp | 423.83K | 0.10% | 235.26K |
| Bnp paribas arbitrage, snc | 292.63K | 0.01% | 208.55K |
| Raymond james financial | 189.36K | 0.00% | 189.36K |
| Great lakes advisors | 169.56K | 0.05% | 169.56K |
| D. e. shaw | 545.66K | 0.01% | 136.87K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | 4.84M | 2.39% | -260.00K |
| Millennium management | 30.47K | 0.00% | -222.27K |
| Schroder investment management group | 298.66K | 0.01% | -216.64K |
| Stephens investment management group | 1.75M | 0.85% | -180.14K |
| Congress wealth management llc / de / | - | - | -177.80K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Raymond james financial | 189.36K | 0.00% | 189.36K | $6.85M |
| Great lakes advisors | 169.56K | 0.05% | 169.56K | $6.13M |
| Norges bank | 125.55K | 0.00% | 125.55K | $4.54M |
| Eversept partners, lp | 105.58K | 0.34% | 105.58K | $3.82M |
| Wedge capital management l l p/nc | 53.33K | 0.03% | 53.33K | $1.93M |
Sold Out
| Holder | Change |
|---|---|
| Claris advisors, llc / mo / | -1.00 |
| Mendota financial group | -5.00 |
| Cva family office | -14.00 |
| Rfp financial group | -27.00 |
| Cape investment advisory | -29.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 137 | -49.63% | 29,073,367 | -51.31% | 52 | 0.45% | 69 | -48.51% | 37 | -58.89% |
| Sep 30, 2024 | 272 | 11.02% | 59,712,047 | 2.23% | 108 | 0.96% | 134 | 15.52% | 90 | 12.50% |
| Jun 30, 2024 | 245 | -3.54% | 58,410,943 | 3.44% | 106 | 1.00% | 116 | 9.43% | 80 | -15.79% |
| Mar 31, 2024 | 254 | 2.42% | 56,466,578 | -1.13% | 103 | 0.94% | 106 | -10.17% | 95 | 7.95% |
| Dec 31, 2023 | 248 | 3.33% | 57,110,886 | 0.73% | 104 | 0.97% | 118 | 9.26% | 88 | -5.38% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 3.41M | 6.12% | 2.19K |
| Delaware Small Cap Core I | 2.00M | 3.62% | -12.37K |
| Macquarie Small Cap Core I | 2.00M | 3.58% | - |
| Vanguard US Total Market Shares ETF | 1.68M | 3.00% | 1.91K |
| Vanguard Total Stock Mkt Idx Inv | 1.66M | 2.98% | 1.49K |
| Vanguard Small Cap Index | 1.34M | 2.40% | 1.09K |
| iShares Russell 2000 ETF | 1.33M | 2.38% | -11.49K |
| Stephens SMID Select Growth | 1.24M | 2.25% | -150.37K |
| Polar Capital Biotech S Inc | 1.25M | 2.24% | - |
| Vanguard Explorer Inv | 953.88K | 1.73% | -129.25K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 21, 2025 | Rubin Jonathan | SVP, Chief Medical Officer | Sell | $36.29K |
| Feb 04, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | $376.24K |
| Jan 28, 2025 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | $27.73K |
| Dec 03, 2024 | Bhatt Padmanabh P. | Sr. VP of IP, CSO | Sell | $467.49K |
| Nov 11, 2024 | NEWHALL CHARLES W III | - | Sell | $387.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | 3 |
| 2024 Q4 | - | 8 |
| 2024 Q3 | - | 1 |
| 2024 Q1 | - | 8 |
SUPN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools